Examkin

Question

Difficulty: MediumImmunizations and Vaccine-Preventable Diseases

Match each adult patient clinical profile to the specific indicated vaccine or vaccine series based on their underlying medical condition according to current immunization guidelines.

  • A 45-year-old man newly diagnosed with cirrhosis due to chronic hepatitis C infection.Both Hepatitis A and Hepatitis B vaccines
  • A 32-year-old woman with profound sensorineural hearing loss scheduled for a cochlear implant placement.Pneumococcal conjugate vaccine
  • A 24-year-old man with a history of recurrent systemic infections who is diagnosed with a terminal complement (C5-C9) deficiency.Both Meningococcal ACWY and Meningococcal B vaccines
  • A 55-year-old man with end-stage renal disease who is initiating outpatient hemodialysis.Hepatitis B vaccine (high-dose or specialized adjuvanted series)

Answer

The cirrhosis patient requires both Hepatitis A and B vaccines; the cochlear implant patient requires a pneumococcal conjugate vaccine; the complement deficiency patient requires both MenACWY and MenB vaccines; and the hemodialysis patient requires a high-dose Hepatitis B vaccine series.
Each clinical scenario presents a unique pathophysiological state that directly correlates with a targeted immunization guideline. Cirrhosis dictates the need for Hep A/B due to the risk of acute-on-chronic liver failure. Cochlear implants pose an anatomical risk for pneumococcal meningitis. Terminal complement deficiency requires comprehensive meningococcal protection because the membrane attack complex is essential for killing Neisseria species. Finally, end-stage renal disease on dialysis requires a specialized high-dose Hepatitis B series due to uremia-induced immune blunting combined with high exposure risk.

Step-by-Step Solution

1
Analyze the immunologic or anatomic vulnerability of the patient with cirrhosis.
Identify that the compromised liver is highly susceptible to acute-on-chronic failure from hepatotropic viruses, necessitating both Hepatitis A and B vaccines.
To prevent severe morbidity from acute viral hepatitis in an already failing organ.
2
Evaluate the surgical risk for the patient undergoing a cochlear implant.
Identify that the implant device bridges the middle ear and the subarachnoid space, necessitating protection against pneumococcus.
Streptococcus pneumoniae is the leading cause of bacterial meningitis in this specific surgical population.
3
Assess the specific immunodeficiency in a patient lacking terminal complement components (C5-C9).
Determine that the inability to form the membrane attack complex specifically impairs the clearance of encapsulated Neisseria species, requiring both available meningococcal vaccines (ACWY and B).
Meningococcal disease is the hallmark severe infection associated with late complement deficiencies.
4
Determine the vaccination needs of a patient starting hemodialysis.
Identify the need for a high-dose or specialized Hepatitis B vaccine series rather than the standard dose.
Uremia causes immune dysfunction that blunts the response to standard vaccine doses, while frequent vascular access increases exposure risk.

Key Concept

Specific adult comorbidities (such as chronic organ failure, anatomic defects, or precise immunodeficiencies) dictate highly targeted vaccination strategies beyond the universal adult schedule.
Rate this question

Topics

Immunizations and Vaccine-Preventable Diseases

More questions from this topic